| |
|
Control |
CRC stage |
|
|
|
|
| |
|
|
IIa |
Ilb |
Ilc |
IIIa |
IIIb |
IV |
| Total |
|
63 |
25 |
3 |
1 |
21 |
9 |
13 |
| Gender |
Male |
34 |
19 |
2 |
0 |
13 |
6 |
6 |
| |
Female |
29 |
6 |
1 |
1 |
8 |
3 |
7 |
| Age |
Mean |
62.9 |
67.9 |
69.0 |
58.0 |
63.0 |
60.0 |
68.2 |
| |
S.D. |
13.7 |
10.6 |
2.0 |
- |
18.1 |
13.7 |
8.5 |
| Cancer location |
Ascending colon |
- |
2 |
1 |
0 |
2 |
1 |
2 |
| |
Transverse colon |
- |
2 |
0 |
0 |
2 |
0 |
2 |
| |
Descending colon |
- |
4 |
0 |
0 |
0 |
1 |
2 |
| |
Sigmoid colon |
- |
11 |
1 |
1 |
7 |
0 |
2 |
| |
Cecum |
- |
1 |
0 |
0 |
0 |
0 |
0 |
| |
Rectum |
- |
5 |
1 |
0 |
10 |
7 |
5 |
Patients with a previous history of CRC or a previous or current diagnosis of cancer
other than CRC were excluded. |
